More migraine treatments than ever have become available in recent years, with more on the way. Discover the many options available in this comprehensive guide.

The global auto-injector market is expected to reach USD 5,713.2 million by 2025 and will grow to USD 23,314.9 million by 2035 at a CAGR of 8.2%. In 2024 revenue of Auto-Injectors was approximately ...

The prefilled syringe formulation is the first DHE auto-injector that patients can self-administer in a ready-to-use form, according to Amneal. The injector does not require refrigeration ...

have taken any of the following medicines in the last 24 hours: sumatriptan, frovatriptan, ergotamine or ergotamine-type medicines, almotriptan, naratriptan, zolmitriptan, eletriptan, or ...

Sumatriptan is available as an auto-injector tool. DHE comes in a prefilled syringe. This type of treatment is performed by a healthcare professional. A doctor will first palpate and identify the ...

“Our MiniJect is a compact patient-centric auto-injector with an extended shelf-life and reduced environmental impact.” Alejandro Zepeda Sahagun, Zeyco’s Pharmaceutical Plant ...

Dijon, France, November 13, 2024 -- Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma company developing the award-winning needle-free ZENEO® auto-injector to deliver life-saving ...

HARTFORD, Conn. (WTNH) — Recently, the Federal Drug Administration announced the approval of nalmefene auto-injector for the emergency treatment of opioid overdose, another tool for combatting ...

On August 7, the U.S. Food and Drug Administration (FDA) approved the nalmefene hydrochloride auto-injector that is used in the treatment of opioid overdose. The treatment is used to treat opioid ...

The US Food and Drug Administration (FDA) has approved the first nalmefene hydrochloride auto-injector (Zurnai; Purdue Pharma LP) for the treatment of known or suspected opioid overdose in people ...

The FDA approved the first nalmefene hydrochloride auto-injector (Zurnai) for use as an emergency treatment for opioid overdose in adults and children 12 years of age and older, the agency ...